financetom
Business
financetom
/
Business
/
DNOW Q3 revenue misses estimates, adjusted EPS beats
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
DNOW Q3 revenue misses estimates, adjusted EPS beats
Nov 5, 2025 4:17 AM

Overview

* DNOW ( DNOW ) Q3 revenue was $634 mln, missing analyst expectations

* Adjusted EPS for Q3 beats analyst expectations

Outlook

* DNOW expects to close merger with MRC Global in Q4 2025

* Company forecasts best full-year earnings ever in terms of EBITDA

* DNOW ( DNOW ) focuses on customer service and innovation for future growth

Result Drivers

* REVENUE GROWTH - DNOW achieved its highest revenue since Q4 2019, driven by strong operational performance

* STRONG CASH POSITION - DNOW ( DNOW ) ended the quarter with $266 mln in cash and zero debt, providing a solid foundation for growth

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Miss $634 mln $637.13

Revenue mln (3

Analysts

)

Q3 Beat $0.26 $0.23 (3

Adjusted Analysts

EPS )

Q3 $28 mln

Adjusted

Net

Income

Q3 Net $25 mln

Income

Q3 $51 mln

Adjusted

EBITDA

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

* Wall Street's median 12-month price target for DNOW Inc ( DNOW ) is $17.00, about 14.1% above its November 4 closing price of $14.60

* The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 17 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US FDA approves Merck's blood pressure therapy
US FDA approves Merck's blood pressure therapy
Mar 26, 2024
(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Merck's ( MRK ) treatment for adults with high blood pressure due to constriction of lung arteries, adding another potential blockbuster drug to the pharmaceutical giant's portfolio. Shares of Merck ( MRK ) were up more than 5% in extended trading. The therapy, branded Winrevair, is approved for treating pulmonary...
Think Research Says No Alternative Buyers Emerge as Shareholder Vote Next Week on Going Private Transaction
Think Research Says No Alternative Buyers Emerge as Shareholder Vote Next Week on Going Private Transaction
Mar 26, 2024
05:29 PM EDT, 03/26/2024 (MT Newswires) -- Think Research ( THKKF ) on Tuesday said it expects to complete a going-private transaction in conjunction with Beedie Investments in the second quarter as a 30-day period to solicit other buyers ended with no competing bids. The healthcare-technologies company said its advisors contacted 34 potential buyers during the go shop period, which...
What's Going On With Rumble Stock?
What's Going On With Rumble Stock?
Mar 26, 2024
Rumble Inc. ( RUM ) shares are trading higher Tuesday, possibly in sympathy with Trump Media & Technology Group Corp. after the company debuted on the Nasdaq Tuesday.  What To Know: Trump Media & Technology Group debuted on the Nasdaq Tuesday. Rumble CEO Chris Pavlovski congratulated the company and its CEO on the social media platform, X.  A big congrats...
BRIEF-Steven Cohen Reports 5.0% Passive Stake In Fox Corp As Of March 25 - SEC Filing
BRIEF-Steven Cohen Reports 5.0% Passive Stake In Fox Corp As Of March 25 - SEC Filing
Mar 26, 2024
March 26 (Reuters) - Fox Corp ( FOXA ): * STEVEN COHEN REPORTS 5.0% PASSIVE STAKE IN FOX CORP AS OF MARCH 25 - SEC FILING Source text for Eikon: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved